Stella M. Sung

Directeur Général chez Aegea Biotechnologies, Inc.

Profil

Dr. Stella M.
Sung is a Managing Director at Pearl Street Venture Funds.
She brings over a decade of experience in the healthcare sector to Pearl Street Venture Funds.
Prior to joining Coastview Capital, she was a General Partner at Oxford Bioscience Partners.
She has eight years of direct experience in life science venture capital and has led venture rounds of financing for six transactions, co-founded two biotechnology companies, served on 6 Boards of Directors and served as Chairman of the Board for four biotechnology companies.
Previously, she focused on life science and health care investments at Advent International, a global private equity firm that has raised over $6 billion in cumulative capital to date.
Dr. Sung received her B.S.
in chemistry from The Ohio State University and her Ph.D.
in chemistry from Harvard University, where she was a National Science Foundation Pre-Doctoral Fellow.

Postes actifs de Stella M. Sung

Sociétés	Poste	Début
Pearl Street Venture Funds	Private Equity Investor	01/05/2004
Aegea Biotechnologies, Inc.	Directeur Général	01/09/2019

Anciens postes connus de Stella M. Sung

Sociétés	Poste	Fin
ImmunoActiva, Inc.	Fondateur	01/09/2019
TAURIGA SCIENCES, INC.	Directeur Général	13/07/2015
TAURIGA SCIENCES, INC.	Directeur Général	01/01/2015
Coastview Capital LLC	Private Equity Investor	31/12/2005
AVITA Medical Pty Ltd.	Corporate Officer/Principal	-

Formation de Stella M. Sung

Harvard University	Doctorate Degree
The Ohio State University	Undergraduate Degree